<p>The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.</p>

Subscribe

Title Date published
BoB@JPM: Academia To Industry With Oncolytics' Matt Coffey, Ph.D. 2023-02-13
BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D. 2023-02-06
Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D. 2023-01-30
Modality-Agnostic Drug Discovery With Cullinan Oncology's Nadim Ahmed 2023-01-23
Women In Biotech With Bill & Melinda Gates MRI's Piper Trelstad, Ph.D. 2023-01-16
Computational Drug Discovery With Gain Therapeutics' Matthias Alder 2023-01-09
Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany 2023-01-02
AI & Computational Biology With Recursion's Chris Gibson, Ph.D. 2022-12-26
Allan Shaw On Financing Biopharma Innovation 2022-12-19
Gene Therapy For Chronic Inflammation With Xalud's Howard Rutman, M.D. 2022-12-12
The Antibody Engine With Abpro's Chan Brothers 2022-12-05
In-Vivo CAR T Update With Umoja Biopharma's David Fontana, Ph.D. 2022-11-28
RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati 2022-11-21
Tick-Derived Therapeutic Molecules With Akari Therapeutics' Rachelle Jacques 2022-11-14
Product vs. Platform With Surface's Vito Palombella, Ph.D. and Robert Ross, M.D. 2022-11-07
Leveraging Lymph Nodes With Elicio's Dr. Peter DeMuth 2022-10-31
Engineering Proteins For Food Allergies With Ukko's Dr. Anat Binur 2022-10-24
Anatomy Of A VC Deal With 4BIO's Dima Kuzmin & Ray Therapeutics' Paul Bresge 2022-10-17
Oncology Discovery Advances With AbbVie's Steve Davidsen, Ph.D. 2022-10-10
IND For TIL Therapy With Obsidian Therapeutics' Paul Wotton, Ph.D. 2022-10-03
1234567891011121314

Comments about Business Of Biotech

comments powered by Disqus
Advertisment: